Stockscreener 앱 받기
1.62
52.83%
0.56
시장 영업 전:
1.73
0.11
+6.79%
전일 마감가:
$1.06
열려 있는:
$1.12
하루 거래량:
66.39M
Relative Volume:
32.96
시가총액:
$28.68M
수익:
-
순이익/손실:
$-112.46M
주가수익비율:
-0.9878
EPS:
-1.64
순현금흐름:
$-99.89M
1주 성능:
+458.62%
1개월 성능:
+710.41%
6개월 성능:
+45.95%
1년 성능:
+62.00%
1일 변동 폭
$1.11
$1.74
1주일 범위
$0.29
$1.74
52주 변동 폭
$0.1311
$1.80
보 바이오파마 Stock (VOR) Company Profile
명칭
Vor Biopharma Inc
전화
617-655-6580
주소
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
VOR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
1.62 | 28.68M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.20 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
525.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
326.09 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
551.22 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
242.07 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
보 바이오파마 Stock (VOR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-07-26 | 개시 | Wedbush | Outperform |
| 2022-04-27 | 개시 | Goldman | Neutral |
| 2021-12-17 | 개시 | H.C. Wainwright | Buy |
| 2021-12-03 | 개시 | Robert W. Baird | Outperform |
| 2021-12-02 | 개시 | Oppenheimer | Outperform |
| 2021-10-19 | 개시 | JMP Securities | Mkt Outperform |
| 2021-03-25 | 개시 | B. Riley Securities | Buy |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-03-03 | 개시 | Evercore ISI | Outperform |
| 2021-03-02 | 개시 | Goldman | Sell |
| 2021-03-02 | 개시 | Stifel | Buy |
모두보기
보 바이오파마 주식(VOR)의 최신 뉴스
Short Interest in Vor Biopharma Inc. (NYSE:VOR) Increases By 51.8% - Defense World
Vor Biopharma Inc (VOR) Stock: A Year of Highs and Lows in the Market - investchronicle.com
Market Insights: Triller Group Inc (ILLR)’s Notable Gain of 1.91, Closing at 0.69 - DWinneX
Vor Biopharma Inc (VOR) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com
Data-Based Insights About Vor Biopharma Inc (VOR) - Stocksregister
Vor Biopharma Inc. (NYSE:VOR) Given Average Recommendation of “Hold” by Analysts - Defense World
Northern Trust Corp Acquires 44,252 Shares of Vor Biopharma Inc. (NYSE:VOR) - Defense World
Cambridge biotech company researching blood cancers to close, lay off 155 - Yahoo Finance
Vor Biopharma Inc (NASDAQ: VOR) Stock Forecast: Could Pass $6 In A Year - Stocksregister
Vor Biopharma’s SWOT analysis: biotech firm halts programs, explores options By Investing.com - Investing.com South Africa
Vor Biopharma’s SWOT analysis: biotech firm halts programs, explores options - Investing.com
Vor Biopharma Approves Share Increase at Annual Meeting - TipRanks
Vor Biopharma Appoints Robert Ang as CFO - TipRanks
What Did We Note About Insider Trading At Vor Biopharma Inc (NASDAQ: VOR)? - Stocksregister
FMR LLC's Strategic Acquisition of Vor Biopharma Inc Shares - GuruFocus
Vor Biopharma Inc. (NYSE:VOR) Given Consensus Rating of “Hold” by Analysts - Defense World
Vor Biopharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Vor Biopharma Inc. SEC 10-Q Report - TradingView
Research Analysts’ Recent Ratings Updates for Vor Biopharma (VOR) - Defense World
Vor Biopharma (NYSE:VOR) Cut to “Hold” at Jones Trading - Defense World
HC Wainwright Reaffirms Neutral Rating for Vor Biopharma (NYSE:VOR) - Defense World
Vor Biopharma’s (VOR) Neutral Rating Reiterated at Wedbush - Defense World
Vor Biopharma (VOR) Downgraded by HC Wainwright & Co. from Buy t - GuruFocus
VorBio (VOR) Downgraded Amid Strategic Review Announcement | VOR Stock News - GuruFocus
Vor Biopharma (VOR) Drops Sharply After Downgrades and Operational Halt - GuruFocus
Stifel cuts Vor Biopharma stock rating amid clinical and financial concerns By Investing.com - Investing.com South Africa
VorBio (VOR) Downgraded as Company Explores Strategic Alternativ - GuruFocus
Stifel cuts Vor Biopharma stock rating amid clinical and financial concerns - Investing.com Canada
Vor Biopharma stock draws downgrades (VOR:NASDAQ) - Seeking Alpha
Layoff Tracker: Shape, Vor Cut Workforces - BioSpace
Vor Biopharma (VOR) Downgraded by JMP Securities | VOR Stock New - GuruFocus
Baird Downgrades Vor Biopharma to Neutral From Outperform - marketscreener.com
This International Paper Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - Benzinga
Vor Biopharma (VOR) Downgraded by HC Wainwright & Co. from Buy to Neutral | VOR Stock News - GuruFocus
Closing Bell Recap: Vor Biopharma Inc (VOR) Ends at 0.16, Reflecting a -70.12 Downturn - DWinneX
VorBio (VOR) Downgraded as Company Shifts Strategy | VOR Stock News - GuruFocus
VorBio (VOR) Downgraded as Company Explores Strategic Alternatives | VOR Stock News - GuruFocus
Stifel Downgrades Vor Biopharma, Inc. (VOR) to Hold - StreetInsider
Baird cuts Vor Biopharma stock rating, slashes target to $0.25 By Investing.com - Investing.com Nigeria
Baird cuts Vor Biopharma stock rating, slashes target to $0.25 - Investing.com
Jones Trading cuts Vor Biopharma stock rating to Hold By Investing.com - Investing.com Nigeria
Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings - Benzinga
Jones Trading cuts Vor Biopharma stock rating to Hold - Investing.com
Vor Biopharma stock plummets on operation wind-down - Investing.com Australia
Vor Biopharma stock plummets on operation wind-down By Investing.com - Investing.com Canada
Vor Biopharma Terminates CFO Han Choi - marketscreener.com
Vor Bio Announces Exploration Of Strategic Alternatives To Maximize Shareholder Value - marketscreener.com
Wedbush Downgrades Vor Biopharma to Neutral From Outperform, Adjusts Price Target to $0.40 From $7 - marketscreener.com
Vor Bio (VOR) Downgraded to Hold as Strategic Alternatives Explored | VOR Stock News - GuruFocus
Jones Trading Downgrades Vor Biopharma, Inc. (VOR) to Hold - StreetInsider
Dow Jumps Over 200 Points; US Initial Jobless Claims Fall - Benzinga
보 바이오파마 (VOR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
보 바이오파마 주식 (VOR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Attar Eyal C. | CHIEF MEDICAL OFFICER |
Feb 13 '25 |
Sale |
1.42 |
2,227 |
3,162 |
126,625 |
0.78%
0.23%
자본화:
|
볼륨(24시간):